News

03/08/2010 - Argos Therapeutics Presents Positive Phase 2 Data of its Arcelis™ Personalized Immunotherapy Platform


Read More »

03/05/2010 - Achillion to Present at Upcoming Investor Conferences


Read More »

03/04/2010 - Argos Therapeutics Publishes Positive Immune Response, Safety and Manufacturing Data for its Arcelis™ HIV Program in Clinical Immunology


Read More »

03/02/2010 - Argos Therapeutics Appoints Jeffrey D. Abbey President and Chief Executive Officer


Read More »

02/25/2010 - EKOS Corporation Announces a Groundbreaking Study for the Treatment of Intracerebral and Intraventricular Hemorrhage Using Ultrasound


Read More »

02/17/2010 - TRANSMOLECULAR REPORTS ANNEXIN A2 IS A NOVEL BINDING PARTNER FOR TM601


Read More »

02/17/2010 - Achillion Announces Positive 96-Week Data for Elvucitabine at the 17th Annual Conference on Retroviruses and Opportunistic Infections


Read More »

02/17/2010 - EndoGastric Reports 3,500th Natural Orifice Surgery Procedure Performed at Advanced CME Course on TIF


Read More »

02/08/2010 - Achillion to Present at 12th Annual BIO CEO and Investor Conference


Read More »

02/02/2010 - Achillion Announces Closing of Underwriters' Over-Allotment Option


Read More »

02/01/2010 - Achillion Announces License Agreement for Elvucitabine Development in China


Read More »

01/28/2010 - Achillion Announces Nomination of ACH-2684 as Lead Clinical Candidate in Resistance-Focused HCV Program


Read More »

01/25/2010 - Achillion to Host Corporate and Clinical Update Conference Call on Monday, February 1, 2010


Read More »

01/22/2010 - Achillion Prices $21.4 Million Public Offering of Common Stock


Read More »

01/21/2010 - Achillion Announces Proposed Public Offering of Common Stock


Read More »

01/18/2010 - EKOS Corporation Supports the Dutch Randomized Trial Comparing Standard Catheter-Directed Thrombolysis vs. Ultrasound-Accelerated Thrombolysis for Thrombo-Embolic Infra-Inguinal Disease


Read More »

01/18/2010 - EKOS Corporation Announces Clinical Study for the Treatment of


Read More »

01/11/2010 - Achillion Announces Additional Positive Phase 1b Data With ACH-1625 to Treat Hepatitis C


Read More »

01/08/2010 - EndoGastric Solutions Reports Extension of U.S. Clinical Evidence Supporting TIF


Read More »

12/31/2009 - EndoGastric Solutions Announces Key Patent Issued


Read More »

12/15/2009 - Achillion Regains Compliance With Nasdaq Listing Rules


Read More »

12/15/2009 - Achillion Announces Positive Preliminary Phase 1b Proof of Concept Data With ACH-1625 to Treat Hepatitis C


Read More »

12/09/2009 - EndoGastric Announces Advanced Transoral Fundoplication Educational Course Initiative for 2010


Read More »

11/29/2009 - New Tool for Radiologists and Imaging Centers: Broncus LungPoint Procedure Planning Revolutionizes Referrals to Chest Physicians


Read More »

11/25/2009 - ENDOGASTRIC SOLUTIONS ANNOUNCES ADDITIONAL FINANCIAL INVESTMENT


Read More »

11/20/2009 - EKOS® Touted as a New and Aggressive Intervention for Treatment OfChronic Deep Venous Thrombosis at VEITHsymposium in New York


Read More »

11/18/2009 - EKOS Corporation Launches the New EkoSonic® MACH4e at VEITHsymposium™ in New York


Read More »

11/17/2009 - Achillion Receives Notice From NASDAQ


Read More »

11/17/2009 - Broncus Reports Early EASE Trial Results for Airway Bypass


Read More »

11/11/2009 - NOVAVISION LAUNCHES FIRST TRULY PORTABLE HEAD MOUNTED PERIMETER SCREENING DEVICE


Read More »

11/06/2009 - Achillion Reports Third Quarter Results


Read More »

11/02/2009 - Broncus Technologies and Medico’s Hirata Enter Into Exclusive Partnership for LungPoint™ and Yield™ Product Lines in Japan


Read More »

11/02/2009 - John C. Lincoln First Hospital to Use Broncus LungPoint System


Read More »

10/29/2009 - Achillion to Present at Three Upcoming Conferences


Read More »

10/28/2009 - Novocell is the Recipient of a Disease Team Award for $20 Million from the California Institute for Regenerative Medicine to Develop a Stem Cell Therapy for the Treatment of Diabetes


Read More »

10/22/2009 - TRANSMOLECULAR’S 131I-TM601 SHOWN TO IMPROVE SURVIVAL IN RECURRENT MALIGNANT GLIOMA


Read More »

10/21/2009 - Argos Therapeutics Presents Positive Phase 2 Viral Load and Immune Response Data for Arcelis™ HIV Program at the AIDS Vaccine 2009


Read More »

09/29/2009 - MedVantx Subsidiary Announces Contract Award By the Montana Association of Health Care Purchasers


Read More »

09/28/2009 - Achillion Completes Phase 1a Trial of ACH-1625; Begins Dosing in Phase 1b Segment With HCV-Infected Patients


Read More »

09/03/2009 - Achillion to Present At the Thomas Weisel Partners Annual Healthcare Conference


Read More »

08/24/2009 - EndoGastric Solutions Announces Initiation of Clinical Study to Demonstrate Efficacy of StomaphyX for Revisional Weight Loss Surgery


Read More »

08/17/2009 - MedVantx Named to Inc. 500List of Fastest Growing Companies


Read More »

08/03/2009 - Achillion to Present At the Canaccord Adams 29th Annual Global Growth Conference


Read More »

07/30/2009 - Achillion Reports Second Quarter and Six Month Financial Results


Read More »

10/31/2008 - Mitralign Initiates It's First European Study


Read More »